United States · FDA National Drug Code directory
Eptifibatide
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70436-163_4a614df8-4e1d-d610-e063-6294a90a7d7c
- Product NDC
- 70436-163
- Form
- INJECTION
- Composition / generic term
- eptifibatide
- Labeler
- Slate Run Pharmaceuticals, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20190601
- Source listing expiry
- 20271231
Source-listed ingredients
- EPTIFIBATIDE — .75 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 100 mL in 1 VIAL (70436-163-80) · 70436-163-80
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →